Live feed
Filing
SC 13G/A
SC 13G/A0001274173-18-000092·BIOCRYST PHARMACEUTICALS INC
Schedule 13G ownership disclosure
BIOCRYST PHARMACEUTICALS INC
Security class unavailable · CUSIP: 09058V103
Event date: 2018-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 11,096,183
- Percent of class
- 11.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-18-000092
- Form type
- SC 13G/A
- Filer
- BIOCRYST PHARMACEUTICALS INC
- CIK
- CIK 882796
- Filed
- Jul 10, 2018
- Reporting period
- Jun 30, 2018
- Description
- Schedule 13G beneficial ownership